Clinical Trial

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-09-21; most recent amendment 2026-03-02.
Status change: Recruiting → Active, Not Recruiting 2025-04-03
Status change: Not Yet Recruiting → Recruiting 2023-03-28
Trial Details
NCT Number NCT05554094
Lead Sponsor Ohio State University
Conditions PTSD, Stress Disorders, Traumatic, Stress Disorders, Post-Traumatic, Trauma and Stressor Related Disorders, Mental Disorder
Enrollment 15 participants
Start Date 2023-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-04